Company
Headquarters: North Sydney, NSW, Australia
Employees: 7
CEO: Mr. James Edward Manning
$5.2 Million
USD as of Jan. 1, 2026
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $158.96 B |
| Vertex Pharmaceuticals Incorporated | $115.92 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $82.28 B |
| Marinomed Biotech AG | $70.11 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Mawson Infrastructure Group Inc., a digital infrastructure provider, operates in cryptocurrency mining and digital asset infrastructure activities in the United States and Australia. It owns and operates modular data centers. The company matches energy infrastructure with mobile data center solutions enabling the proliferation of blockchain technology. The company is based in North Sydney, Australia.
Mawson Infrastructure Group, Inc. has the following listings and related stock indices.
Stock: OTC: MIGI